title: "Methylene blue should be relegated to rescue use and not as first-line therapy" cannot become a paradigm.
authors.affiliation: Department of Surgery and Anatomy Ribeirão Preto School of Medicine University of São Paulo São Paulo, Brazil.
authors.forename: Paulo R B
authors.initials: PR
authors.lastname: Evora
authors.affiliation: Department of Surgery and Anatomy Ribeirão Preto School of Medicine University of São Paulo São Paulo, Brazil.
authors.forename: Alfredo
authors.initials: A
authors.lastname: José Rodrigues
authors.affiliation: Department of Surgery and Anatomy Ribeirão Preto School of Medicine University of São Paulo São Paulo, Brazil.
authors.forename: Andrea C
authors.initials: AC
authors.lastname: Celotto
mesh_terms: D000931:Antidotes / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008751:Methylene Blue / Q000009:adverse effects*; D056987:Vasoplegia / Q000188:drug therapy*
chemical_list: D000931:Antidotes; D008751:Methylene Blue